Skip to main content

. 1959 Jun;38(6):907–915. doi: 10.1172/JCI103873

STUDIES OF THE URICOGENIC EFFECT OF 2-SUBSTITUTED THIADIAZOLES IN MAN^{^*}

Irwin H Krakoff ^1,^2,^3,⁴, M Earl Balis ^1,^2,^3,⁴

PMCID: PMC293241 PMID: 13654527

907

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BENEDICT J. D., FORSHAM P. H., ROCHE M., SOLOWAY S., STETTEN D., Jr The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout. J Clin Invest. 1950 Aug;29(8):1104–1111. doi: 10.1172/JCI102343. [DOI] [PMC free article] [PubMed] [Google Scholar]
BENEDICT J. D., ROCHE M., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism. 1952 Jan;1(1):3–12. [PubMed] [Google Scholar]
CULLEN J. H., EARLY L. J., FIORE J. M. The occurrence of hyperuricemia during pyrazinamide-isoniazid therapy. Am Rev Tuberc. 1956 Aug;74(2 Pt 1):289–292. doi: 10.1164/artpd.1956.74.2-1.289. [DOI] [PubMed] [Google Scholar]
DUBBS C. A., DAVIS F. W., ADAMS W. S. Simple microdetermination of uric acid. J Biol Chem. 1956 Jan;218(1):497–504. [PubMed] [Google Scholar]
ELLISON R. R., KARNOFSKY D. A., STERNBERG S. S., MURPHY M. L., BURCHENAL J. H. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease. Cancer. 1954 Jul;7(4):801–814. doi: 10.1002/1097-0142(195407)7:4<801::aid-cncr2820070419>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
KARNOFSKY D. A. The use of the developing chick embryo in pharmacologic research. Stanford Med Bull. 1955 May;13(2):247–259. [PubMed] [Google Scholar]
KELLY H. J., SKIPPER H. E., TOMISEK A. J. Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors. Arch Biochem Biophys. 1956 Oct;64(2):437–455. doi: 10.1016/0003-9861(56)90287-9. [DOI] [PubMed] [Google Scholar]
KRAKOFF I. H., KARNOFSKY D. A. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON). Am J Physiol. 1958 Oct;195(1):244–250. doi: 10.1152/ajplegacy.1958.195.1.244. [DOI] [PubMed] [Google Scholar]
KRAKOFF I. H., MAGILL G. B. Effects of 2-ethylamino-1, 3, 4 thiadiazole HCI on uric acid production in man. Proc Soc Exp Biol Med. 1956 Mar;91(3):470–472. doi: 10.3181/00379727-91-22295. [DOI] [PubMed] [Google Scholar]
LEVENBERG B., MELNICK I., BUCHANAN J. M. Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo. J Biol Chem. 1957 Mar;225(1):163–176. [PubMed] [Google Scholar]
LOEVINGER R., BERMAN M. Efficiency criteria in radioactivity counting. Nucleonics. 1951 Jul;9(1):26–39. [PubMed] [Google Scholar]
MAGILL G. B., MYERS W. P., REILLY H. C., PUTNAM R. C., MAGILL J. W., SYKES M. P., ESCHER G. C., KARNOFSKY D. A., BURCHENAL J. H. Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease. Cancer. 1957 Nov-Dec;10(6):1138–1150. doi: 10.1002/1097-0142(195711/12)10:6<1138::aid-cncr2820100608>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
MURPHY M. L., DAGG C. P., KARNOFSKY D. A. Comparison of teratogenic chemicals in the rat and chick embryos; an exhibit with additions for publication. Pediatrics. 1957 Apr;19(4 Pt 1):701–714. [PubMed] [Google Scholar]
SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
WYNGAARDEN J. B. Overproduction of uric acid as the cause of hyperuricemia in primary gout. J Clin Invest. 1957 Oct;36(10):1508–1515. doi: 10.1172/JCI103547. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES